Colorectal Cancer Clinical Trial
Official title:
Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer: a Prospective Multicenter Cohort Study
Data of 100 colorectal cancer patients with liver metastases who received stereotactic radiotherapy of Cyberknife or microwave ablation in the multicenter of the research group from June 2019 to May 2021 were collected, as well as follow-up data.To evaluate the clinical efficacy of stereotactic radiotherapy and microwave ablation in liver metastases.In addition, the local control rate and side effects of stereotactic radiotherapy and microwave ablation in the treatment of liver metastases were explored, and the efficacy and safety of different doses of stereotactic radiotherapy were determined.
In the study,data of 100 colorectal cancer patients with liver metastases who received
Cyberknife stereotactic radiotherapy or microwave ablation in the multi-center of the
research group from June 2019 to May 2021 were collected, as well as follow-up data.
1. Radiation: Stereotactic Radiotherapy 1.1 Equipment: Accuray VSI Cyberknife stereotactic
radiotherapy platform, simulated positioning CT machine, MR, positron emission computed
tomography PET-CT, vacuum pad.
1.2 Radiotherapy localization: CT, MRI and PETCT were used to simulate localization.
1.3 Relevant Definitions of Tumor Targets CT, MRI, PET-CT fusion, combined with MRI
location and PET-CT location image for sketching.
To delineate target areas and organs at risk. GTV: Combining localization and fusion
images to delineate the tumors seen PTV = GTV + 0-10mm Dangerous organs: The stomach,
duodenum, jejunum, ileum, colon, spinal cord and esophagus were delineated on the base
sequence of CT plain scan.
The target area should be approved by at least one physician in charge or by a physician
in charge.
1.4 Target volume radiation dose: According to the volume, location, organ function and
other factors, the dosage of radiotherapy was determined. The range of BED value of
radiotherapy was 90-120 when the distance between the tumor and gastrointestinal tract
was more than 5 mm (alpha/beta=10) and 70-90 when the distance between the tumor and
gastrointestinal tract was less than 5 mm (alpha/beta=10).
1.5 Normal Tissue Limit: Reference to TG101 Report
2. Microwave ablation 2.1 Preoperative positioning and planning: 2.1.1 Determine the fixing
device: generally choose vacuum pad to fix 2.1.2 Choosing the right position: The
principle is to choose the position that is easy to operate, taking into account the
comfort and tolerance of patients.
2.1.3 CT scan 2.1.4 The range of tumors was determined by CT images. In principle, at the
maximum level, the skin points corresponding to the vertical center of the tumor are the
marker points of the locating needle. At the same time, the center of the tumor was taken as
the origin point, and the longitudinal and transverse cross lines were drawn on the patient's
body surface. Roughly delineate the range of tumors according to CT in body surface 2.2
Surgery and intraoperative optimization 2.2.1 Posture reduction and fixation of patients
2.2.2 Oxygen inhalation, ECG and blood pressure monitoring 2.2.3 Installation of 3D Printing
Planar Coordinate Template Fixer 2.2.4 Routine disinfection, cave towel laying, local
infiltration anesthesia, fixing 3D printing plane coordinate template according to the range
of tumors determined by physical examination and preoperative plan, and adjusting the
direction of plane template by protractor.
2.2.5 Puncture locating needle and puncture assistant fixing needle in 4 directions of tumor
margin.
2.2.6The real-time CT 2.5mm image was imported into the navigation system, the puncture
needle was marked, the puncture needle was simulated, and the resolution of the template was
adjusted accurately.
2.2.7 Enhanced CT scan to determine the position and angle of template and pin accurately
2.2.8 Layer by layer puncture according to preoperative plan 2.2.9 After inserting the
ablation antenna to the reserved position, scan CT again to confirm whether the puncture
needle has reached the planned position. 2.2.10 Complete ablation of tumors as planned.
2.3Postoperative observation 2.3.1 With the assistance of the staff in the hospital, they
will be transported back to the ward by flat car with their families.
2.3.2 Re-measurement of blood pressure and heart rate 2.3.3Observe whether there is bleeding
or exudation at the puncture point after operation, and give hemostasis and pain relief if
necessary.
To evaluate the clinical efficacy of stereotactic radiotherapy and microwave ablation in
liver metastases after these treatment.In addition, the local control rate and side effects
of stereotactic radiotherapy and microwave ablation in the treatment of liver metastases were
explored, and the efficacy and safety of different doses of stereotactic radiotherapy were
determined.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |